Detection of genetic abnormalities by using CVS and FISH prior to fetal reduction in sonographically normal appearing fetuses

Prenatal Diagnosis

Volumn 33, Issue 10, 2013, Pages 940-944

  Rosner, Mara ^a   Pergament, Eugene ^b   Andriole, Stephanie ^c   Gebb, Juliana ^a   Dar, Pe'er ^a   Evans, Mark I ^c,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Northwestern Reproductive Genetics   (United States)

^c Fetal Medicine Foundation of America   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; FEMALE; FETAL REDUCTION; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS KARYOTYPING; FIRST TRIMESTER PREGNANCY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE 47,XXY; MAJOR CLINICAL STUDY; MONOSOMY X; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX CHROMOSOME MOSAICISM; TRISOMY 13; TRISOMY 21; TURNER SYNDROME;

ADULT; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; FALSE NEGATIVE REACTIONS; FEMALE; GENETIC TESTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PREGNANCY; PREGNANCY REDUCTION, MULTIFETAL; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84884980160     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4213     Document Type: Article

References (28)

1. Evans MI, Britt DW. Multifetal pregnancy reduction: evolution of the ethical arguments. Semin Reprod Med 2010;28:295-302.
2. Evans MI, Fletcher JC, Zador IE, et al. Selective first-trimester termination in octuplet and quadruplet pregnancies: clinical and ethical issues. Obstet Gynecol 1988;71:289-96.
3. Evans MI, Kaufman MI, Urban AJ, et al. Fetal reduction from twins to a singleton: a reasonable consideration? Obstet Gynecol 2004;104:102-9.
4. Stone J, Ferrara L, Kamrath J, et al. Contemporary outcomes with the latest 1000 cases of multifetal pregnancy reduction (MPR). Am J Obstet Gynecol 2008;199:406.e1-4.
5. Hook EB. Rates of chromosomal abnormalities at different maternal ages. Obstet Gynecol 1981;58:282-5.
6. Roesler M, Wise L, Katayama KP. Karyotype analysis of blighted ova in pregnancies achieved by in vitro fertilization. Fertil Steril 1989;51:1065-66.
7. Lam R, Ma S, Robinson WP, et al. Cytogenetic investigation of fetuses and infants conceived through intracytoplasmic sperm injection. Fertil Steril 2001;76:1272-75.
8. Evans MI, Andriole S. Screening and Testing in Multiples. In Odibo A, Krantz DA (eds): Prenatal Screening and Diagnosis. Clin Lab Med 2010;30:643-54.
9. Brambati B, Tului L, Camurri L, Guercilena S. First-trimester fetal reduction to a singleton infant or twins: outcome in relation to the final number and karyotyping before reduction by transabdominal chorionic villus sampling. Am J Obstet Gynecol 2004;191:2035-40.
10. Evans MI, Britt DW. Medical, ethical, and legal aspects of fetal reduction. In Ethical and Legal Aspects of ART, Schenker JL (ed.). Walter De Gruyter GmbH & Co. Berlin: New York, 2011:121-30.
11. Ferrara L, Gandhi M, Litton C, et al. Chorionic villus sampling and the risk of adverse outcome in patients undergoing multifetal pregnancy reduction. Am J Obstet Gynecol 2008;199:408.e1-e4.
12. Evans MI, Berkowitz RL, Wapner RJ, et al. Multifetal pregnancy reduction (MFPR): improved outcomes with increased experience. Am J Obstet Gynecol 2001;184:97-103.
13. Lewi L, Deprest J, Hecher K. The vascular anastomoses in monochorionic twin pregnancies and their clinical consequences. Am J Obstet Gynecol 2013;208:19-30.
14. Baker C, Feldman B, Shalhoub AG, et al. Demographic factors for utilization of invasive genetic testing after multifetal pregnancy reduction (MFPR). Fetal Diagn Ther 2003;18:140-3.
15. Brambati B, Tului L, Baldi M, Guercilena S.Genetic analysis prior to selective fetal reduction in multiple pregnancy: technical aspects and clinical outcome. Human Reprod 1995;10:818-25.
16. Evans MI, Krantz DA, Hallahan TW, Sherwin JE. Under-measurement of nuchal translucencies: implications for screening. Obstet Gynecol 2010;116:815-8.
17. Evans MI, Krantz D, Hallahan T, Sherwin J. Impact of NT credentialing by FMF, NTQR, or both upon screening distribution and performance. Ultrasound Obstet Gynecol 2012;39:181-4.
18. Evans MI, Rosner M, Andriole S, et al. Evolution of gender preferences in multiple pregnancies. Prenat Diagn 2013. DOI: 10.1002/pd.4167.
19. Evans MI, Andriole S, Pergament E, et al. Paternity balancing. Fetal Diagn Ther 2013. DOI: 10.1159/000351857.
20. Musci TJ, Fairbrother G, Baley A, et al. Non-invasive prenatal testing with cell-free DNA: US physician attitude toward implementation in clinical practice. Prenat Diagn 2013. doi:10.1002/pd.4091.
21. Allyse MA, Sayres LC, Harvard M, et al. Best ethical practices for clinicians and laboratories in the provision of non-invasive prenatal testing. Prenat Diagn 2013. doi: 10.1002/pd.4144.
22. Lench N, Barrett A, Fielding S, et al. The clinical implementation of non-invasive prenatal diagnosis for single gene disorders: challenges and progress made. Prenat Diagn 2013. doi:10.1002/pd.4124.
23. Cuckle H, Benn P, Pergament E. Maternal cfDNA screening for Down syndrome - a cost sensitivity analysis. Prenat Diagn 2013. DOI:10.1002/pd4157
24. Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 2013. DOI:10.1002/3945
25. Wapner RJ, Driscoll DA, Simpson JL. Integration of microarray technology into prenatal diagnosis: counseling issues generated during the NICHD clinical trial. Prenat Diagn 2013. DOI:10.1002/pd3863
26. Canick JA, Kloza, EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012;32:1-5.
27. Lau TK, Jiang F, Chan MK, et al. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013;26:434-7.
28. Feldman B, Aviram Goldburg A, Evans MI. Interphase FISH for prenatal diagnosis of common aneuploids. Methods Mol Biol 2002;204:219-41.